When Cost-Sharing Waivers for COVID-19 Treatment Expire for People with Private Insurance Plans August 24, 2020 Slide About 88% – nearly nine in ten – enrollees in the individual and fully-insured group markets are covered by plans that have taken action to limit out-of-pocket costs for patients undergoing treatment for COVID-19 since the start of the pandemic. However, after accounting for waivers that have already expired (20%) or are scheduled to expire by the end of September (16%), just over half of enrollees in these plans will still be eligible for waived cost-sharing in October and beyond.
What Do We Know About Spending Related to Public Health in the U.S. and Comparable Countries? September 30, 2020 Slideshow
How Build Back Better Would Affect Drug Costs December 8, 2021 Slide Provisions in the bill that would lower prescription drug costs and reduce federal drug spending would take effect over the next several years, starting in 2023.
What Are the Key Prescription Drug Provisions in the Build Back Better Act? December 8, 2021 Slideshow
Where Do the Democratic Candidates Stand on Health Reform and Prescription Drug Prices? February 25, 2020 Slideshow
